Aaron Kellogg, Ph.D.
Affiliations: | 2008 | The University of Toledo |
Area:
Medicine and Surgery, Neuroscience BiologyGoogle:
"Aaron Kellogg"Mean distance: 53433
Parents
Sign in to add mentor| Rodica Pop-Busui | grad student | 2008 | The University of Toledo | |
| (Effect of cyclooxygenase (COX)-2 activation on diabetic neuropathy.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Gualeni B, Rajpar MH, Kellogg A, et al. (2013) A novel transgenic mouse model of growth plate dysplasia reveals that decreased chondrocyte proliferation due to chronic ER stress is a key factor in reduced bone growth. Disease Models & Mechanisms. 6: 1414-25 |
| Pop-Busui R, Oral E, Raffel D, et al. (2009) Impact of rosiglitazone and glyburide on nitrosative stress and myocardial blood flow regulation in type 2 diabetes mellitus. Metabolism: Clinical and Experimental. 58: 989-94 |
| Kellogg AP, Converso K, Wiggin T, et al. (2009) Effects of cyclooxygenase-2 gene inactivation on cardiac autonomic and left ventricular function in experimental diabetes. American Journal of Physiology. Heart and Circulatory Physiology. 296: H453-61 |
| Kellogg AP, Cheng HT, Pop-Busui R. (2008) Cyclooxygenase-2 pathway as a potential therapeutic target in diabetic peripheral neuropathy. Current Drug Targets. 9: 68-76 |
| Kellogg AP, Wiggin TD, Larkin DD, et al. (2007) Protective effects of cyclooxygenase-2 gene inactivation against peripheral nerve dysfunction and intraepidermal nerve fiber loss in experimental diabetes. Diabetes. 56: 2997-3005 |
| Kellogg AP, Pop-Busui R. (2005) Peripheral nerve dysfunction in experimental diabetes is mediated by cyclooxygenase-2 and oxidative stress. Antioxidants & Redox Signaling. 7: 1521-9 |